StockData
Pennant Group, Inc. logo

Pennant Group, Inc. (PNTG) stock

PNTGNasdaqServices-Health ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 13/307% above fair value
$35.81−0.69 (-1.89%)

Close on Nov 18, 2026Market cap $1.25BP/E 39.8Yield –

Pennant revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Pennant's revenue for the twelve months ending Jun 30, 2026 was $1.10B, up 37.9% year over year. For fiscal 2025 it was $947.71M, up 36.3% from the year before. The highest annual figure on record is $947.71M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$947.71M+36.3%
FY2024Dec 31, 2024$695.24M+27.6%
FY2023Dec 31, 2023$544.89M+15.1%
FY2022Dec 31, 2022$473.24M+7.6%
FY2021Dec 31, 2021$439.69M+12.5%
FY2020Dec 31, 2020$390.95M+15.5%
FY2019Dec 31, 2019$338.53M+18.3%
FY2018Dec 31, 2018$286.06M+14.0%
FY2017Dec 31, 2017$250.99M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$297.98M+35.8%
Q1 FY2026Mar 31, 2026$285.36M+36.0%
Q4 FY2025Dec 31, 2025$289.32M+53.2%
Q3 FY2025Sep 30, 2025$229.04M+26.8%
Q2 FY2025Jun 30, 2025$219.50M+30.1%
Q1 FY2025Mar 31, 2025$209.84M+33.7%
Q4 FY2024Dec 31, 2024$188.89M+29.4%
Q3 FY2024Sep 30, 2024$180.69M+28.9%
Q2 FY2024Jun 30, 2024$168.75M+27.6%
Q1 FY2024Mar 31, 2024$156.92M+24.1%
Q4 FY2023Dec 31, 2023$145.95M+17.1%
Q3 FY2023Sep 30, 2023$140.19M+18.5%
Q2 FY2023Jun 30, 2023$132.28M+13.7%
Q1 FY2023Mar 31, 2023$126.46M+11.0%
Q4 FY2022Dec 31, 2022$124.67M+11.5%
Q3 FY2022Sep 30, 2022$118.35M+5.7%
Q2 FY2022Jun 30, 2022$116.32M+5.4%
Q1 FY2022Mar 31, 2022$113.91M+7.8%
Q4 FY2021Dec 31, 2021$111.77M+3.5%
Q3 FY2021Sep 30, 2021$111.92M+13.7%
Q2 FY2021Jun 30, 2021$110.35M+19.0%
Q1 FY2021Mar 31, 2021$105.66M+15.0%
Q4 FY2020Dec 31, 2020$107.97M+20.6%
Q3 FY2020Sep 30, 2020$98.40M+11.3%
Q2 FY2020Jun 30, 2020$92.74M+12.1%
Q1 FY2020Mar 31, 2020$91.85M+17.9%
Q4 FY2019Dec 31, 2019$89.49M+18.8%
Q3 FY2019Sep 30, 2019$88.40M+21.2%
Q2 FY2019Jun 30, 2019$82.73M–
Q1 FY2019Mar 31, 2019$77.91M–
Q4 FY2018Dec 31, 2018$75.34M–
Q3 FY2018Sep 30, 2018$72.95M–

More Pennant figures

See a number that looks wrong?